Tokyo, Japan

Yu Yamaguchi

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Tokyo, JP (2001)
  • Chiyoda-ku, JP (2022)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yu Yamaguchi: Innovator in Biocompatible Materials

Introduction

Yu Yamaguchi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biocompatible materials, holding a total of 3 patents. His innovative work focuses on methods for producing decellularized materials for transplantation and novel prostaglandin derivatives.

Latest Patents

One of Yu Yamaguchi's latest patents is a method for producing decellularized material for transplantation. This method involves harvesting a branch-bearing blood vessel from a vertebrate animal, decellularizing the blood vessel, and adhering a portion where a branch has been excised to close the vessel through a protein denaturation treatment. Additionally, he has developed a graft composition consisting of a biocompatible material that includes this decellularized transplantation material. Another significant patent relates to a novel production method of a prostaglandin derivative or a pharmaceutically acceptable salt thereof, which is useful as a medicament.

Career Highlights

Throughout his career, Yu Yamaguchi has worked with notable companies such as NEC Corporation and AGC Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the field of biocompatible materials.

Collaborations

Yu has collaborated with esteemed colleagues, including Yasushi Matsumura and Yusuke Nagai. These partnerships have fostered a creative environment that has led to the development of his innovative patents.

Conclusion

Yu Yamaguchi is a distinguished inventor whose work in biocompatible materials has the potential to impact the medical field significantly. His patents reflect a commitment to advancing technology for transplantation and medicinal applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…